NovoPath’s unique position provides us with unsurpassed insight into the operation of the anatomic pathology lab. Clearly, the market has responded very favorably to our unmatched introduction and support of best-in-class AP products.
PRINCETON, NJ (PRWEB) December 29, 2012
NovoPath, Inc., a leader in Anatomic Pathology (AP) Best-of-Breed Software Solutions completes 2012 with stellar results, including strong sales to new laboratory partners that exceeded expectations. Significant installations were achieved in all market sectors including multi-hospital groups, university-based medical centers, community hospitals, and national, regional and local reference labs. Additionally, NovoPath systems were the first choice not only for Dermatopathology labs, but also for specialty labs focused on Hematopathology, GYN and Non-Gyn Cytology, Cytogenetics, Molecular Pathology and Veterinary Pathology.
A key 2012 milestone was the establishment of a strategic partnership with a major healthcare services and information technology leader focused on a complete offering to the hospital IT enterprise-wide market. Just prior to the start of the year, 2011/2012 ONC-ATCB certification for NovoPath Version 8.0 helped drive business in those forward-looking labs, supporting clients focused on CMS Meaningful Use Criteria.
Another important milestone included the attainment of Gold ISV Competency, signifying another best-in-class ability. This elite status demonstrates NovoPath’s continued commitment to meet their customers’ evolving needs in today’s dynamic business environment, and distinguish itself within the top 1 percent of the Microsoft Partner Ecosystem.
Product development continued at a rapid clip: 2012 saw the release of NovoPath 8.0, quickly followed by NovoOutreach 7.8, NovoBilling 7.8, and NovoVoice 7.8, providing ongoing enhancements to the growing group of laboratory partners. Additional best-in-class firsts include the launch of NovoNotifier Mobile, the first smartphone apps for Android and Apple users, enabling secure on-the-go access to full-length AP reports for clinicians receiving reports from NovoPath partner laboratories.
As recognized experts, NovoPath staff were invited to publish on topics including, putting lean process improvement and BI tools to work in the AP lab, achieving meaningful use, information technology impacting the future of pathology, EMR, EHR, HITECH, ONC-ATCB, HL7 and more.
“NovoPath’s unique position provides us with unsurpassed insight into the operation of the anatomic pathology lab.” said Rick Callahan, VP of Sales and Marketing. “Clearly, the market has responded very favorably to our unmatched introduction and support of best-in-class AP products.”
About NovoPath, Inc.:
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.